AKT/PKB Signaling: Navigating Downstream

Slides:



Advertisements
Similar presentations
Specialized signaling pathways 1: RTK associated pathways
Advertisements

Date of download: 7/5/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Insulin signaling pathways. The insulin signaling pathways provide.
Cell Signaling Pathways – A Case Study Approach
AMPK—Sensing Energy while Talking to Other Signaling Pathways
Eph-Ephrin Bidirectional Signaling in Physiology and Disease
Sustaining Proliferative Signaling and Evading Growth Suppressors
You have identified a novel cytoplasmic protein
Miriam Marqués, Francisco X. Real  European Urology 
IRS-1: Auditing the effectiveness of mTOR inhibitors
Figure 1 mTOR pathway activation
The Akt-mTOR tango and its relevance to cancer
Figure 3 Defects in the T cell receptor signalling pathway
Kinase inhibitors: Vice becomes virtue
Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3- Kinase/AKT/Mammalian Target of Rapamycin Pathway  Gozde Akgumus, Fengqi.
A Sweet New Role for EGFR in Cancer
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
mTORC1: Turning Off Is Just as Important as Turning On
Figure 1 mTOR complex biology
In-vitro regulation of primordial follicle activation: challenges for fertility preservation strategies  Michael J. Bertoldo, Kirsty A. Walters, William.
Doubling Down on mTOR Inhibition: Harnessing ZEBRA for Insights
Volume 29, Issue 3, Pages (March 2016)
The pathway signalling starts with the binding of insulin or growth factors to insulin receptors. The pathway signalling starts with the binding of insulin.
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Jing Zhang, Thomas M. Roberts, Ramesh A. Shivdasani  Gastroenterology 
Maria M. Mihaylova, David M. Sabatini, Ömer H. Yilmaz  Cell Stem Cell 
Vascular dysfunction in diabetes mellitus
PHLPPing It off: Phosphatases Get in the Akt
Identification of TOR Signaling Complexes
Is REDD1 a Metabolic Éminence Grise?
Great Expectations for PIP: Phosphoinositides as Regulators of Signaling During Development and Disease  Lara C. Skwarek, Gabrielle L. Boulianne  Developmental.
Host Translation at the Nexus of Infection and Immunity
PTEN Enters the Nuclear Age
PKB Binding Proteins Cell
Complementing T Cells’ Functions: Bringing in Metabolism Matters
Figure 1 The insulin signalling pathway
Rapamycin: One Drug, Many Effects
Taru Muranen, Funda Meric-Bernstam, Gordon B. Mills  Cancer Cell 
The PI3K Pathway in Human Disease
FGFR Signaling as a Target for Lung Cancer Therapy
Autophagy in kidney disease and aging: lessons from rodent models
IRS-1: Auditing the effectiveness of mTOR inhibitors
An Emerging Role of mTOR in Lipid Biosynthesis
AMPK—Sensing Energy while Talking to Other Signaling Pathways
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
Nat. Rev. Nephrol. doi: /nrneph
Live Longer sans the AT1A Receptor
Pin-Pointing a New DAP Kinase Function: The Peptidyl-Proly Isomerase Pin1 Is Negatively Regulated by DAP Kinase-Mediated Phosphorylation  Shani Bialik,
AKT/PKB Signaling: Navigating the Network
Figure 1 The mTOR signalling pathway
Bryan Krock, Nicolas Skuli, M. Celeste Simon  Cell Metabolism 
Insulin Action under Arrestin
Signalling links in the liver: Knitting SOCS with fat and inflammation
Rapamycin: One Drug, Many Effects
Yan Feng, MD, Praveena S. Thiagarajan, PhD, Patrick C. Ma, MD 
mTOR and Akt Signaling in Cancer: SGK Cycles In
Alex Kentsis, A. Thomas Look  Cell Stem Cell 
Simon Ekman, MD, PhD, Murry W. Wynes, PhD, Fred R. Hirsch, MD, PhD 
Brian K. Kennedy, Dudley W. Lamming  Cell Metabolism 
Tobias B. Huber, Gerd Walz, E Wolfgang Kuehn  Kidney International 
Philip Cohen, Marianna Tcherpakov  Cell 
Volume 104, Issue 4, Pages (February 2001)
Dysregulation of the mTOR Pathway Secondary to Mutations or a Hostile Microenvironment Contributes to Cancer and Poor Wound Healing  Richard A.F. Clark,
Brief Review – Growth Factors and Receptors
Cell Signaling by Receptor Tyrosine Kinases
Successful targeting of ErbB2 receptors—is PTEN the key?
Turning Reciprocal Feedback Regulation into Combination Therapy
T Helper Cell Differentiation: Understanding the Needs of Hierarchy
Tackling Resistance to PI3K Inhibition by Targeting the Epigenome
The Ribosome and TORC2: Collaborators for Cell Growth
Presentation transcript:

AKT/PKB Signaling: Navigating Downstream Brendan D. Manning, Lewis C. Cantley  Cell  Volume 129, Issue 7, Pages 1261-1274 (June 2007) DOI: 10.1016/j.cell.2007.06.009 Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 1 Upstream Activation of Akt by Growth Factors Also depicted is the complex relationship between Akt signaling and mTOR. Activated receptor tyrosine kinases (RTKs) activate class I phosphatidylinositol 3-kinase (PI3K) through direct binding or through tyrosine phosphorylation of scaffolding adaptors, such as IRS1, which then bind and activate PI3K. PI3K phosphorylates phosphatidylinositol-4,5-bisphosphate (PIP2) to generate phosphatidylinositol-3,4,5-trisphosphate (PIP3), in a reaction that can be reversed by the PIP3 phosphatase PTEN. AKT and PDK1 bind to PIP3 at the plasma membrane, and PDK1 phosphorylates the activation loop of AKT at T308. RTK signaling also activates mTOR complex 2 (mTORC2) through a currently unknown mechanism, and mTORC2 phosphorylates Akt on the hydrophobic motif S473, which can be dephosphorylated by the S473 phosphatase PHLPP. Akt activates mTOR complex 1 (mTORC1) through multisite phosphorylation of TSC2 within the TSC1-TSC2 complex, and this blocks the ability of TSC2 to act as a GTPase-activating protein (GAP) for Rheb, thereby allowing Rheb-GTP to accumulate. Rheb-GTP activates mTORC1, which phosphorylates downstream targets such as 4E-BP1 and the hydrophobic motif on the S6 kinases (S6Ks; T389 on S6K1). PDK1 phosphorylates the activation loop on the S6Ks (T229 on S6K1) in a reaction independent of PDK1 binding to PIP3. Akt can also activate mTORC1 by phosphorylating PRAS40, thereby relieving the PRAS40-mediated inhibition of mTORC1. Once active, both mTORC1 and S6K can phosphorylate serine residues on IRS1, which targets IRS1 for degradation, and this serves as a negative feedback mechanism to attenuate PI3K-Akt signaling. See text for references to recent reviews detailing Akt regulation and mTOR signaling. Cell 2007 129, 1261-1274DOI: (10.1016/j.cell.2007.06.009) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 2 Cellular Functions of Ten Akt Substrates Akt-mediated phosphorylation of these proteins leads to their activation (arrows) or inhibition (blocking arrows). Regulation of these substrates by Akt contributes to activation of the various cellular processes shown (i.e., survival, growth, proliferation, glucose uptake, metabolism, and angiogenesis). As illustrated by these ten targets, a high degree of functional versatility and overlap exists amongst Akt substrates. See text for detailed descriptions of substrates and functions. Cell 2007 129, 1261-1274DOI: (10.1016/j.cell.2007.06.009) Copyright © 2007 Elsevier Inc. Terms and Conditions